Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, the list price for Wegovy, Ozempic and Rybelsus, Novo’s semaglutide products, will be $675 across the board in the U.S. This reduction…

Prank trojan in Russia, European Commission data leak, and other cybersecurity news – ForkLog
Prank trojan in Russia, European Commission data leak, and other cybersecurity news ForkLog

.webp?w=0&resize=0,0&ssl=1)
